97.93
price down icon0.07%   -0.07
after-market Handel nachbörslich: 97.97 0.04 +0.04%
loading

Finanzdaten der Nuvalent Inc-Aktie (NUVL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -25.30
Operating Expenses
9.29%
102.23
112.70 104.57 94.81 86.30
Operating Income/Loss
9.29%
-102.23
-112.70 -104.57 -94.81 -86.30
Nonoperating Income/Loss
69.90%
-16.33
-9.609 5.063 10.39 11.71
Income/Loss From Continuing Operations Before Tax
3.07%
-118.55
-122.31 -99.51 -84.42 -74.59
Income Tax Expense/Benefit
14.39%
0.151
0.132 0.145 0.157 0.171
Income/Loss From Continuing Operations After Tax
3.05%
-118.70
-122.44 -99.65 -84.58 -74.76
Net Income/Loss
3.05%
-118.70
-122.44 -99.65 -84.58 -74.76
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.86%
0.8199
72.14 71.84 71.61 1.5941
Diluted Average Shares
98.86%
0.8199
72.14 71.84 71.61 1.5941
Basic Earnings Per Share
7.06%
-1.58
-1.70 -1.39 -1.18 -1.06
Diluted Earnings Per Share
7.06%
-1.58
-1.70 -1.39 -1.18 -1.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):